BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Wayne State University

Headquarters: Detroit, MI, United States
Year Founded: 1868
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Mar 12, 2024
Discovery & Translation

Distillery spotlight: new mitochondrial mechanisms from academia

Correcting mitochondrial dynamics, metabolic control of pathogenic or therapeutic cells emerge among translational innovations in BioCentury’s survey of 2023 publications
BioCentury | Jan 18, 2024
Distillery Therapeutics

Targeting cytochrome c peroxidase activity for Barth Syndrome

BioCentury | May 16, 2023
Emerging Company Profile

Ray: a genotype-agnostic approach to reversing blindness with one-time therapy

With $100M in series A funding, ‘2.0’ gene therapy company aims to treat retinitis pigmentosa using a channelrhodopsin variant designed for greater light sensitivity
BioCentury | Nov 23, 2022
Data Byte

Translational spotlight on East-West innovation 

Collaborations between investigators at Asian and Western universities in BioCentury’s Distillery present licensing and partnering opportunities
BioCentury | Apr 27, 2022
Emerging Company Profile

Ashvattha branches out with $69M series B for dendrimer therapies

JHU spinout advancing COVID-19, ophthalmic programs based on hydroxyl dendrimer platform
BioCentury | Aug 27, 2021
Distillery Therapeutics

IL-33 treatment for MRSA infection following liver transplant

BioCentury | Feb 28, 2019
Distillery Therapeutics

Infectious disease

BioCentury | Jan 3, 2017
Distillery Techniques

Assays and screens

BioCentury | Mar 31, 2016
Distillery Therapeutics

Therapeutics: Adenosine A1 receptor (ADORA1)

BioCentury | Dec 17, 2015
Tools & Techniques

Heartfelt conversion

High efficiency, non-viral cell reprogramming
Items per page:
1 - 10 of 61